OPPORTUNITIES FOR HIGH-COST DRUGS IN INDIA

被引：0
|
作者：
Ramabadran, A. [1 ]
Samuel, J. J. [2 ]
Edathodu, A. [2 ]
Mukku, S. R. [2 ]
机构：
[1] Univ Cambridge, Cambridge, England
[2] Access Infin Ltd, London, England
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN240
引用
收藏
页码：A131 / A131
页数：1
相关论文
共 50 条
  • [41] THE ROLE OF NHS ENGLAND COMMISSIONING POLICIES IN PROMOTING EQUITABLE ACCESS TO HIGH-COST DRUGS
    Anderson, Marina
    RHEUMATOLOGY, 2015, 54 : 13 - 13
  • [42] Access to high-cost drugs for advanced breast cancer in Latin America, particularly trastuzumab
    Barrios, Carlos Henrique
    Reinert, Tomas
    Werutsky, Gustavo
    ECANCERMEDICALSCIENCE, 2019, 13
  • [43] NURSING AS AN ALTERNATIVE TO HIGH-COST CARE
    FAGIN, CM
    AMERICAN JOURNAL OF NURSING, 1982, 82 (01) : 56 - 60
  • [44] The Strategic Value of High-Cost Customers
    Subramanian, Upender
    Raju, Jagmohan S.
    Zhang, Z. John
    MANAGEMENT SCIENCE, 2014, 60 (02) : 494 - 507
  • [45] High-Cost, High-Value Oral Specialty Drugs: More Evidence on the Impact of Cost Sharing in Medicare Part D
    Huntington, Scott F.
    Davidoff, Amy J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (36) : 4307 - +
  • [46] Replacing the high-cost pathologist - Reply
    Grzybicki, DM
    Galvis, CO
    Raab, SS
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (01) : 149 - 150
  • [47] Take control of high-cost asthma
    Flaum, M
    Lung, CL
    Tinkelman, D
    JOURNAL OF ASTHMA, 1997, 34 (01) : 5 - 14
  • [48] Five High-Cost Patient Groups
    Westfall, John M.
    Griswold, Kim
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 (09) : 965 - 965
  • [49] The high-cost business of building jets
    Aboulafia, R
    AEROSPACE AMERICA, 2006, 44 (04) : 13 - 15
  • [50] Willingness to Pay for High-Cost Medications
    Hlatky, Mark A.
    CIRCULATION, 2020, 141 (15) : 1225 - 1226
12345